Sunday, February 26, 2017 3:58:55 PM
The big money is pharma, like GW. Abattis needs to get their license amended for this step. I believe I posted the response from HC a while back. That process is not going to be helped my Rene's failure to operate like a legit company. Unfortunately it could still hurt that Withrow was Tweeting out overly optimistic messages like "almost there", which got his hand slapped and forced the big HC / CSE (?) warning letter.
The nutraceutical product line will face an uphill battle without the amended license for export. There are TONS of other companies in China and South Korea that sell pills that claim to help XYZ. They need to put CBD in there to stand out.
Best chance, IMO, is to get the license amended and sell out to an LP with deep pockets.
Either that or hemp water! LOL, HTH.
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM